Becton, Dickinson and Co. | BDX - Operating Profit


Becton, Dickinson and Co. reported $1.11B in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Agilent USD 444M 45M Jun/2026
Align Technology USD 193.04M 1.72M Sep/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Solventum Corp USD 68M 113M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Teleflex USD -105.77M 178.84M Sep/2026
Terumo JPY 89.48B 58.03B Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026